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Dorsal and medial raphe nuclei participate
differentially in reproductive functions of
the male rat
María E. Ayala1*, Diana E. Velázquez1, Juan L. Mendoza1, Juana Monroy1, Roberto Domínguez1,
Mario Cárdenas2 and Andrés Aragón3,4
Abstract
Background: Innervation of the hypothalamus and median eminence arise from the dorsal and medial raphe nuclei
(DRN and MRN, respectively). The hypothalamus regulates the secretion of gonadotropins, which in turn regulate the
reproductive function of males and females. However, it is not known the role of raphe nuclei in male reproductive
function. Our goal was to investigate the role of the DRN and MRN in the regulation of the testicular function and
secretion of gonadotropins in prepubertal rats.
Methods: Dihydroxytryptamine (5,6-DHT) in ascorbic acid was used to chemically lesion the DRN or MRN. Rats were
treated at 30 days-of-age and sacrificed at 45 or 65 days-of-age. Sham-treated controls were injected with ascorbic acid
only. Negative controls were untreated rats. The damage induced by the 5,6-DHT was monitored in coronal serial
sections of DRN and MRN; only the animals in which lesion of the DRN or MRN was detected were included in this study.
As output parameters, we measured the concentrations of noradrenaline (NA), dopamine (DA) and serotonin
(5-HT) in the anterior (AH) and medial (MH) hypothalamus by high performance liquid chromatography (HPLC);
whereas, circulating concentrations of gonadotropins and sexual steroids were measured by radioimmunoassay.
Seminiferous epithelium and sperm quality were also evaluated.
Results: Lesion of DRN or MRN does not induced changes in concentrations of LH, progesterone, and testosterone.
Compared with the control group, the sham or lesion of the DRN or MRN did not modify noradrenaline or dopamine
concentrations in the AH and MH at 45 or 65 days of age. Meanwhile, serotonin concentrations decreased significantly
in lesioned rats. Lesion of DRN induced significantly lower concentrations of FSH regardless of age; similar lesion in
the MRN had no impact on FSH levels. Sperm concentration and motility were significantly decreased in the
same animals. The lesion of the MRN does not induced changes in the seminiferous epithelium or gonadotropin
levels. Our results suggest that raphe nuclei regulate differentially the male reproductive functions.
Conclusions: The DRN but not the MRN regulates the secretion of gonadotropins and testicular function.
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Background
The regulation of testicular function depends on the inte-
gration of neuroendocrine mechanisms that involve the
hypothalamus-hypophysis axis [1]. Gonadotropins FSH
and LH, secreted by the hypophysis, regulate spermato-
genesis. Gonadotropin secretion is modulated by gonado-
tropin releasing hormone (GnRH), which is produced by
the hypothalamus [2]. Furthermore, the neural informa-
tion from extrahypothalamic areas, such as the DRN and
MRN raphe nuclei, regulates the secretion of gonadotro-
pins in adult female [3–6] and male [7–9] rats.
Ascending serotonergic projections from the DRN and
MRN innervate the hypothalamus and median eminence
[8, 10–12] and synapses with GnRH neurons, suggesting
the participation of serotonin on GnRH and gonadotropin
secretion [13–15]. In adult male rats, LH secretion is un-
changed after sectioning of fibers arising from the MRN.
In contrast, LH secretion decreases after sectioning of fi-
bers arising from the DRN [7], or increases following
chemical lesion by injection of 5,7-dihydroxytryptamine
(5,7-DHT) into the DRN [9]. These results cannot be at-
tributed solely to the serotonergic system, because the
DRN and MRN contain both serotonergic and non-
serotonergic neurons [16–18]. Furthermore, 5,7-DHT is a
non-specific neurotoxin, as it damages both serotonergic
and noradrenergic neurons [19].
In the female, the serotonergic system, arising from the
DRN and MRN, differentially participates in the regulation
of gonadotropin secretion. This can be attributed to the
complexity of these nuclei, because serotonergic neurons
from the DRN and MRN exhibit distinct anatomical, elec-
trophysiological, and functional properties [20–23]. These
distinct features suggest different functional roles for the
two serotonergic systems. Despite increased interest in the
functional properties of these individual raphe nuclei, very
little is known about the participation of the serotonergic
system, originating from the raphe nuclei, in the regula-
tion of testicular function in the adult male rat. Further-
more, no information exists on the participation of these
nuclei during puberty in the male rat.
Some derivates of amphetamine exert differential neuro-
toxic effects on the serotonergic neurons from the DRN
and MRN; the serotonergic neurons from the DRN are
more affected than MRN cells [20, 21, 24]. The neurotoxic
effects of these drugs on serotonergic neurons are related
to the formation of toxic metabolites, such as 5,6-dihy-
droxytryptamine (5,6-DHT) [21, 25–27].
The objective of this work was to investigate the role of
the serotonergic system from the DRN and MRN on the
secretion of gonadotropins and reproductive function of
male rats. We achieved our objective by lesioning, with
5,6-DHT, the serotonergic neurons of the raphe nuclei
and evaluating the circulating gonadotropins and sexual
steroids, seminiferous epithelium, and sperm quality.
Materials and Methods
Experimental strategy
Male rats of the CII-ZV strain (n = 160), from our own
breeding stock, were maintained under controlled light
conditions (lights on from 05:00 to 19:00), with free access
to food and tap water. We allocated animals randomly to
one of three groups described below. At 30 days of age,
the MRN or DRN of prepuberal male rats was chemically
lesioned. All animals were sacrificed at 45 or 65 days of
age, 15 or 35 days after lesion, circulating concentrations
of sexual steroids and gonadotropins, seminiferous epithe-
lium, and sperm quality were evaluated.
Rationales for use of prepuberal animals and schedule
of sampling were the permissive role of serotonin toward
pubertal maturation, the age at which spermatogenesis is
completed in the testis, and the time required for the
sperm traverse the epididymis.
Ethical approval
We conducted all experiments in strict accordance with
the Mexican Law of Animal Treatment and Protection
Guidelines. The Institutional Ethics Committee of the
Facultad de Estudios Superiores Zaragoza, Universidad
Nacional Autónoma de México approved the protocol
(Letter date 01/03/2012).
Control Group
The animals were untreated.
Lesioned groups
Animals were anesthetized with sodium pentobarbital
(Anestesal, Smith Kline Norden of Mexico, Monterrey
Nuevo León; 35 mg kg−1 of body weight, i.p.) and
placed in a stereotaxic apparatus. The head skin was
opened, the skull drilled and a number 29-needle
(13 mm long) introduced following parameters of the
stereotaxic atlas by Paxinos and Watson [28]. Coordi-
nates for the DNR are: AP = 0.7 mm from lambda, H =
3.3 mm, and L = 6.4 mm at a 30° angle in relation to its
perpendicular axis from the dorsal raphe. For MRN:
AP = 0.5 mm, H = 4.9 mm, and L = 8.0 mm at a 35°
angle in relation to its perpendicular axis. To produce
the lesion of the DRN or the MRN, the needle was
connected via tubing to a 100 μl Hamilton syringe
mounted on a microinjection pump (MCA/100 Biona-
lytical Systems, Inc., West Lafayette, In, USA). 10 μg of
5,6-DHT (Sigma Chemical Co., St Louis, Mo, USA) dis-
solved in 2.5 μl of 0.05 % ascorbic acid (pH 3.5) was
injected at an infusion rate of 1 μl/min. 5,6-DHT is a
serotonergic-specific neurotoxin [6]. The 5,6-DHT dose
was selected based on previous experiments, because
10 μg generated a selective depletion of serotonin con-
centration in the hypothalamus (50 %) but does not im-
pact catecholamine concentration [29].
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Sham-operated groups
Animals were treated with the same parameters used in
the lesion groups, but were injected with 2.5 μl of 0.05 %
of ascorbic acid; lesion of the DRN or the MRN.
Autopsy Procedure
The animals were killed by bleeding under ether anesthesia.
The brain was quickly removed and placed in cold saline
solution and frozen in liquid nitrogen. After careful removal
of the nerves and optic chiasm, the anterior and medium
hypothalamus were dissected following the parameters
described previously [28]. The anterior hypothalamus
(Bregma 20.8 to Bregma 21.8) included the removal of the
lateral and median pre-optic nuclei, the suprachiasmatic,
the paraventricular, the periventricular, and the stria ter-
minal pre-optic area. The medial hypothalamus (Bregma
22.3 to Bregma 23.2) included the median eminence
and arcuate nucleus. Both hypothalamic regions were
stored at −70 °C, until the concentrations of serotonin,
and its metabolite 5-HIAA, were measured using HPLC.
Blood was collected from the trunk of the animals,
allowed to clot, and subsequently centrifuged at 3000 rpm.
The serum supernatant was collected and stored at −20 °C.
We measured progesterone, testosterone, LH, and FSH
levels as described below. The testes, epididymis, pros-
tate, and seminal vesicles were dissected and individu-
ally weighed on a precision balance.
Measurement of serotonin, noradrenaline, and dopamine
The amounts of serotonin (5-HT), noradrenaline (NA),
and dopamine (DA), were measured using the method-
ology described by Monroy et al. [6]. Briefly, tissue sam-
ples were weighed and homogenized in 300 μl of 0.1 N
perchloric acid and subsequently centrifuged at
12500 rpm for 30 min at −4 °C. The supernatant was fil-
tered using 0.2 μm regenerated cellulose filters, and 20 μl
of this extract was injected into the high-performance li-
quid chromatography system for analysis. The results are
expressed as ng/mg of weight of tissue.
Hormone determination
Serum concentrations of progesterone and testosterone
were measured by specific radioimmunoassay (RIA), using
kits purchased from Diagnostic Products (Los Angeles,
CA, USA). The intra- and inter-assay coefficients of vari-
ation were 5.3 and 9.87 % for progesterone and 4.3 and
7.8 % for testosterone. The detection limits for progester-
one and testosterone were 0.09 and 0.005 ng/ml, respect-
ively. The results are expressed as ng/ml.
Concentrations of LH and FSH were measured by RIA,
with the reagents and protocol supplied by the National
Hormone and Pituitary Programs (Baltimore, MD, USA).
The values are expressed in ng/ml in terms of the reference
preparations of NIH LH-RP2 and FSH-RP2. The intra- and
inter-assay coefficients of variation were 7.91 % and 5.74 %
for LH and 9.3 and 6.82 % for FSH. The detection limits
for LH and FSH were 0.05 and 0.01 ng/ml, respectively.
Sperm quality
Evaluation of sperm quality was performed in animals of
65 days-of-age, because at this age male rats have mature
sperm present in the vas deferens. The content of vas def-
erens was obtained and placed in 2 ml of Tyrode’s salt so-
lution (Sigma Chemical Co., St Louis, Mo, USA) at 37 °C
and gently mixed to homogenize the suspension. A drop
of the sperm suspension was placed on a slide for evalu-
ation of motility. For each animal, 200 spermatozoa were
analyzed [30, 31] at 100x total magnification using a
phase-contrast microscope (Nikon, Tokyo, Japan). The
percentage of motile sperm was defined as the ratio of
cells showing movement to the total number of cells x
100. Sperm viability was determined using 1 % trypan blue
(Sigma Chemical Co., St Louis, Mo, USA) following the
technique described [30] and 200 cells were analyzed for
each animal; results are expressed as percentage of viabil-
ity. Sperm concentration was determined in a Neubauer
chamber (PROPER Lumycite, 1/100 mm depth), results
are presented as 1x106 cells/ml.
Analysis of seminiferous epithelium
The right testis of each animal was fixed by immersion in
Bouin solution, followed by dehydration and embedding
in paraffin wax. Serial 10 μm sections were obtained and
stained with periodic acid Schiff (PAS)-hematoxylin.
From each animal, fifty seminiferous tubules, approxi-
mately round, were taken randomly and two diameters
were measured: the maximum diameter, and the diameter
perpendicular to the maximum. The following formula was
used to estimate the area: area = πr2, where r = (diameter
one + diameter two)/4. Results are presented as mean ± sd
of area in each experimental group.
Staging was realized for each tubule evaluated for area;
it was realized by following the development of the acro-
some, as reported previously [32]. Each tubule staged was
searched for gross histopathological changes. Results are
presented as mean ± se, of percentage from each stage of
seminiferous epithelium, in each experimental group.
Brain histology
After dissecting the hypothalamus, the caudal portion
of the brain was fixed in 10 % formalin for at least
48 h. Brains were frozen and sectioned serially at
40 μm in the coronal plane using a cryostat kept at
−20 °C. The sections were placed on glass slides and
later stained with cresyl violet (Sigma Chemical Co.,
St Louis, Mo, USA) to confirm the trajectory of the
needle, location of the injection site (Fig. 1a, b), and
extent of the lesion. Based on the histological
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examination of the lesions, only animals with
complete lesion of the DRN or MRN were included
in this study.
The lesion of the DRN or MRN was determined by
light microscopy. The damaged area was unstained,
while the healthy tissue was stained violet.
The lesion of the DRN or MRN (Fig. 1) was consid-
ered complete when the injured area included the rostral
and medial region of the nucleus, and the caudal region
was not affected. Also, the dorsal, ventral, and lateral
subdivisions of the nucleus were damaged with less de-
struction of the adjacent area, the substantia grisea
periventricularis.
Statistical analysis
The normality of the data was corroborated graphically in
different experiments by checking residuals. The body and
organ weights, sperm motility, sperm viability, serum con-
centration of hormones, as well as serotonin, noradrenaline
and dopamine concentrations were analyzed by two-way
ANOVA, considering chemical treatment as factor and age
of animals as block. Tukey test was used as post hoc test.
Proportions of stages of seminiferous epithelium, among
treatments, were tested for independence by Pearson Chi-
squared test. Comparison of the area of seminiferous tu-
bules, in each stage of cycle of seminiferous epithelium,
was realized by one way ANOVA for unbalanced models,
followed by linear contrast of means. The results were con-
sidered significant at the P < 0.05 level. All analysis were re-
alized with R version 3.1.2 [33] and packages car [34], vcd
[35–37], rattle [38], and lattice [39], running on a MacBook
with MacOsX version 10.10.1.
Results
Effects of the sham operation on the DRN or MNR
Compared to the control group, sham operations to the
DRN or MRN did not modify the body, testis, prostate, or
seminal vesicle weight (Table 1), nor the noradrenaline
and dopamine concentrations in the anterior and medial
hypothalamus of animals at either 45 or 65 days-of-age
(Table 2). Similarly, no significant differences were ob-
served on the 5-HT concentrations in the anterior or
Fig. 1 Diagrammatic representation of location of lesion sites. Dorsal
(a) or medial raphe nuclei (b) on coronal sections (Bregma −7.8 mm).
The area filled with gray circles represents the extent of the lesion. The
figure was created on the basis of the Atlas of Paxinos and Watson
[28]. Abbreviations: Aq, cerebral aqueduct; CG, central gray; XSCP,
decussation superior cerebellar peduncle
Table 1 Effects of chemical lesion of the DRN or MRN raphe nuclei on body weight and sexual accesory glands (grams) (Mean ± S.E.M.)
Group n Body Weight Testis Prostate Seminal Vesicle
45 Days
Control 16 161 ± 5.3 0.847 ± 0.06 0.19 ± 0.04 0.17 ± 0.08
Sham DRN 20 157 ± 3.4 0.829 ± 0.02 0.14 ± 0.01 0.08 ± 0.01
Lesion DRN 14 153 ± 3.7 0.771 ± 0.06 0.09 ± 0.01 0.06 ± 0.08
Sham MRN 11 155 ± 4.2 0.739 ± 0.08 0.16 ± 0.05 0.07 ± 0.01
Lesion MRN 10 159 ± 4.5 0.718 ± 0.09 0.17 ± 0.08 0.07 ± 0.02
65 Days
Control 22 256 ± 4.3 1.426 ± 0.02 0.28 ± 0.02 0.35 ± 0.01
Sham DRN 20 267 ± 3.4 1.481 ± 0.03 0.23 ± 0.02 0.30 ± 0.02
Lesion DRN 22 250 ± 5.9 1.403 ± 0.04 0.22 ± 0.02 0.25 ± 0.02
Sham MRN 10 267 ± 10.6 1.443 ± 0.03 0.36 ± 0.05 0.31 ± 0.02
Lesion MRN 15 277 ± 4.1 1.521 ± 0.03 0.37 ± 0.19 0.35 ± 0.01
Sham; sham operation; DRN, dorsal raphe nucleus; MRN, medial raphe nucleus
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medial hypothalamus of animals with sham operation on
the DRN (Fig. 2). Sham operation to the MRN resulted in
a decrease of serotonin in the medial hypothalamus at
45 days, and an increase in the anterior hypothalamus of
animals sacrificed at 65 days of age (Fig. 2).
Sham operations to the DRN or MRN did not modify
the gonadotropin, progesterone, or testosterone concen-
trations (Table 3) or sperm concentration, viability, and
motility (Table 4).
The sham operation to the DRN, in animals sacrificed at
either 45 or 65 days-of-age, did not induce changes in the
proportion of stages of the cycle of seminiferous epithe-
lium (Support information 1), but changes in proportion
of stages I, XI, and XII were observed between ages
(Fig. 3). The area of the seminiferous epithelium (Fig. 4)
and the presence of detached cells in the lumen of semin-
iferous tubules (Table 5), was not changed 15 or 35 days
after the sham operation.
Since the sham operation in the MRN modified some
the parameters analyzed in this study, the effects of le-
sion of the DRN or MRN were compared to their re-
spective sham-operated group.
Effects of the chemical lesion to the DRN or MRN
No significant differences were observed in the weights of
body, testis, prostate, or seminal vesicle between respect-
ive sham-operated animals and DRN or MRN lesioned-
animals sacrificed at either 45 or 65 days of age (Table 1).
The chemical lesion of the DRN or MRN did not mod-
ify the noradrenaline or dopamine concentrations in the
anterior and medial hypothalamus at 45 or 65 days of age
(Table 2). When compared to respective sham operation,
lesion of either the DRN or MRN resulted in a significant
decrease in serotonin concentration in the anterior and
medial hypothalamus of animals sacrificed at 45 or 65 days
of age (Fig. 2).
The lesion of the DRN induced a decrease in FSH con-
centration in rats at 45 or 65 days of age, but the LH, pro-
gesterone, and testosterone serum concentrations were
unchanged in comparison to respective sham-operated
animals. No differences were observed in the FSH, LH,
progesterone, and testosterone serum concentrations in
the animals with a lesion of the MRN and sacrificed at 45
or 65 days of age (Table 3).
The chemical lesion of the DRN induced a lower
sperm concentration and sperm motility, in comparison
with those of the respective sham-operated group; but
Table 2 Effects of chemical lesion of the DRN or MRN raphe nuclei
on neurotransmitters concentrations (ng/mg tissue) (Mean ± S.E.M.)
Anterior Medial
Age Group n NA DA NA DA
45 Days
Control 11 1.48 ± 0.08 0.37 ± 0.14 1.05 ± 0.07 0.35 ± 0.06
Sham DRN 11 1.44 ± 0.09 0.32 ± 0.01 1.10 ± 0.07 0.34 ± 0.05
Lesion DRN 12 1.38 ± 0.18 0.33 ± 0.15 1.33 ± 0.14 0.35 ± 0.04
Sham MRN 6 1.36 ± 0.17 0.28 ± 0.05 1.37 ± 0.13 0.43 ± 0.09
Lesion MRN 6 1.47 ± 0.11 0.31 ± 0.06 1.16 ± 0.17 0.40 ± 0.09
65 Days
Control 10 1.77 ± 0.09 0.14 ± 0.03 1.63 ± 0.09 0.17 ± 0.02
Sham DRN 16 1.62 ± 0.09 0.11 ± 0.03 1.71 ± 0.08 0.14 ± 0.02
Lesion DRN 14 1.71 ± 0.13 0.12 ± 0.01 1.65 ± 0.14 0.18 ± 0.01
Sham MRN 6 1.90 ± 0.08 0.09 ± 0.07 1.83 ± 0.12 0.21 ± 0.03
Lesion MRN 11 1.67 ± 0.14 0.08 ± 0.08 1.63 ± 0.13 0.16 ± 0.02
Sham; sham operation; DRN, dorsal raphe nucleus; MRN, medial raphe nucleus;
noradrenaline, NA; dopamine, DA
Fig. 2 Production of serotonin (5-HT) in the hypothalamus after the
lesion of raphe nuclei. Control rats, with sham operation (Sham) or
lesion induced by the injection of 5,6-Dihydroxytryptamine (5,6DHT)
into the dorsal (DRN) or medial (MRN) raphe nucleus and sacrificed
at 45 or 65 days of age; a anterior hypothalamus; b medial
hypothalamus. Values are mean ± s.e.m. a, P < 0.05 vs. Control group;
b, P < 0.05 vs. Sham DRN; c, P < 0.05 vs. Sham MRN, Tukey test
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the chemical lesion of the MRN had no effect on these
parameters (Table 4). Data of sperm concentration, mo-
tility, and viability are not presented as there were no
sperm in deferens ducts at 45 days-of-age.
At the testicular level, in the animals with a chemical
lesion of DRN there were no changes in proportion of
stages of cycle of seminiferous epithelium at either 45
(P = 0.70757) or 65 days-of-age (P = 0.44587) (Additional
file 1); however, when age at sacrifice was considered,
deviations of independence (P = 2.22 x10−16) were ob-
served at stages I, IV, VI, and XI at 45 days-of-age and I,
II-III, VI, and XI at 65 days-of age (Fig. 3).
In the animals of 45 days-of-age, the area of seminifer-
ous tubules was lower after chemical lesion of the DRN,
as were stages of the cycle of seminiferous epithelium
VII-XIV; however, at 65 days-of-age changes were ob-
served only at stage VII (Fig. 4).
Each of the seminiferous tubules evaluated was searched
for gross abnormalities. The abnormal presence of detached
germ cells, detected in the lumen of seminiferous tubules,
was significantly higher, at stages of the cycle of seminifer-
ous epithelium VII, VIII, X and XII in animals with chem-
ical lesion of DRN at 45 and 65 days-of-age (Table 5).
Discussion
Here we show that the serotonergic system arising from
the DRN stimulates FSH secretion and testicular function,
whereas the serotonergic system arising from the MRN
apparently does not participate in regulation of the secre-
tion of gonadotropins. The reproductive effects, observed
15 days after lesion of the DRN (i.e. at 45 days-of-age,),
are partially alleviated at 65 days-of-age.
Our model of chemical lesion of DRN or MRN nuclei
by 5,6-DHT effectively damaged serotonergic neurons.
This is demonstrated by the fact that serotonin concentra-
tions were low in the anterior and medial hypothalamus,
independently of age of sacrifice, whereas noradrenaline
and dopamine concentrations were unaffected. Our re-
sults are in line with previous reports [29, 40, 41], which
reported that the 5,6-DHT is easily incorporated into se-
rotonergic neurons and has the property of autoxidation;
this autoxidation generates quinones and free radicals that
damage deoxyribonucleic acids, proteins, lipids, and in-
duce the destruction of terminals and axons [40, 41].
The hypothalamus receives serotonergic innervation
from the DRN and MRN [10–12]. As observed in the
present study, serotonin was detected in the hypothalamus
Table 3 Effects of chemical lesion of the DRN or MRN raphe nuclei on hormonal concentrations (Mean ± S.E.M.)
Age at sacrifice Group n FSH (ng/ml of serum) LH (ng/ml of serum) Progesterone (ng/ml of serum) Testosterone (ng/ml of serum)
45 Days
Control 16 10.1 ± 0.66 0.57 ± 0.06 16.6 ± 1.9 0.97 ± 0.14
Sham DRN 20 8.7 ± 0.30 0.37 ± 0.05 12.5 ± 0.91 0.68 ± 0.10
Lesion DRN 14 5.9 ± 0.87a,b 0.33 ± 0.06 10.8 ± 1.2 0.65 ± 0.09
Sham MRN 11 9.6 ± 0.35 0.68 ± 0.06 12.4 ± 2.1 0.82 ± 0.17
Lesion MRN 10 8.6 ± 0.56 0.59 ± 0.08 9.2 ± 2.9 0.97 ± 0.15
65 Days
Control 22 8.7 ± 0.38 0.58 ± 0.03 8.0 ± 1.1 2.43 ± 0.24
Sham DRN 20 8.2 ± 0.30 0.60 ± 0.04 9.5 ± 1.3 2.47 ± 0.11
Lesion DRN 22 5.4 ± 0.35a,b 0.42 ± 0.07 7.6 ± 1.5 1.71 ± 0.11
Sham MRN 10 6.1 ± 0.38 0.75 ± 0.05 4.6 ± 0.8 2.40 ± 0.37
Lesion MRN 15 6.3 ± 0.28 0.75 ± 0.03 4.2 ± 0.5 1.54 ± 0.31
Mean ± s.e.m; Sham; sham operation; DRN, dorsal raphe nucleus; MRN, medial raphe nucleus
ap < 0.05 vs. Control group (two-way ANOVA followed by Tukey's test)
bp < 0.05 vs. Sham DRN (two-way ANOVA followed by Tukey's test)
Table 4 Effects of chemical lesion of the DRN or MRN raphe nuclei on sperm quality, of rats sacrificed at 65 days-of-age (Mean ± S.E.M.)
Group n Sperm concentration (1x106 cells/ml) Sperm motility (%) Sperm viability (%)
Control 22 71.1 ± 4.2 58.7 ± 2.9 60.9 ± 1.4
Sham DRN 20 70.2 ± 4.8 63.1 ± 4.7 58.2 ± 2.7
Lesion DRN 22 41.2 ± 2.8* 39.6 ± 4.4* 52.1 ± 3.5
Sham MRN 10 67.0 ± 2.8 55.0 ± 2.3 57.2 ± 1.8
Lesion MRN 15 71.3 ± 2.7 50.4 ± 2.0 61.7 ± 2.0
Mean ± s.e.m; Sham; sham operation; DRN, dorsal raphe nucleus; MRN, medial raphe nucleus
*p < 0.05 vs. Sham DRN (Two way ANOVA followed by Tukey 's test)
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of animals with chemical lesion of the DRN or MRN, indi-
cating that the production of serotonin was not completely
eliminated in either group. These results are similar to
those reported when a higher dose of the same drug was
injected intraventricularly into prepuberal male rats [42].
Two possibilities could explain the presence of serotonin in
the hypothalamus of the lesioned animals. First, because we
only introduced lesions in DRN or MRN, the presence of
the remaining nucleus could be a source of serotonin in the
hypothalamus. Second, neurons located in the hypothal-
amus could produce serotonin, as previously published
[reviewed in 20].
The decrease of 5-HT concentration in the hypothal-
amus of animals with a lesion of the DRN or MRN was
maintained from 45 until 65 days-of-age. This results
are in line with two facts: 1) 5,6-DHT induce degener-
ation of serotonergic fibers [43], and 2) degeneration of
serotonergic fibers persisted from two weeks to one
month [29, 42, 43].
The mechanism by which the MRN sham operation
modified the serotonin concentration in the hypothal-
amus is unknown. This effect could be related with the
sectioning of serotonergic fibers, during the introduc-
tion of the injection needle. Serotonergic projections of
MRN to the ventromedial hypothalamus and preoptic
area contain fibers, arising from the left and right side
of the nucleus [12]. In all animals with MRN sham op-
eration the needle of microinjection was introduced by
the right side. Then, it is possible that the changes in
serotonin concentration are related to the surgical
trauma of right fibers induced by introduction of the
injection needle, and the hyperactivity of undamaged
left projections arising from the nucleus.
In the present study, the interruption of serotonergic
communication between the DRN and the anterior and
medial hypothalamus diminished the concentrations of
FSH at 45 and 65 days-of-age. The lack of serotonergic
innervation arising from the MRN, did not have an ef-
fect on gonadotropin secretion. On this basis, we sug-
gest the existence of two serotonergic systems: a first
serotonergic system, arising from the DRN, which in-
nervates the preoptic area, stimulates FSH secretion
and sperm production, and does not affect LH secre-
tion; whereas, the second serotonergic system, arising
from the MRN, and the main source of serotonin in the
mediobasal hypothalamus, does not participate in go-
nadotropin secretion. This differential effect could-be
related to two gonadotropin releasing factors, one for
FSH and another for LH, whose existence was previ-
ously suggested [44, 45].
Fig. 3 The lesion in the DRN induced changes in the proportions of stages of the cycle of seminiferous epithelium at 45 or 65 days-of age. Mosaic plot
for stages of the cycle of seminiferous epithelium, treatment, and age at sacrifice. In the mosaic plot each cell of a contingency table is represented by a
rectangle whose area shows the cell frequency or deviation from independence (Friendly, 1994). The area of each cell is proportional to cell frequency.
Cells with positive, negative, or no deviation from independence are filled with blue, red, or gray color, respectively (Please see the look up table at right
side of the mosaic)
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Fig. 4 The area of seminiferous tubules is modified by lesion of the DRN at specific stages of the cycle of the seminiferous epithelium. Values are
medians (horizontal bar in boxes) with 25 %–75 % interquartile ranges (boxes); dotted vertical lines indicate minimum and maximum values;
circles indicate outliers. aP < 0.05 vs Control; bP < 0.05 vs Sham DRN
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Our idea, that the serotonergic system arising from
the DRN participates in the modulation of secretion of
FSH, is supported by results of a previous report [46],
where the treatment of prepuberal male rats with 5-
hydroxytryptophan (5-HTP) leads to an increase in sero-
tonin concentration in the hypothalamus and FSH in
serum. In the preoptic area, there is communication be-
tween serotonergic terminals and GnRH neurons [13,
47, 48]. Also, serotonin in the preoptic area stimulates
FSH secretion, which is mediated by the 5-HT2 receptor
[49]. The GnRH neurons of mouse have several different
serotonin receptors: 5-HT1A, 5-HT3A, and 5-HT4 [50].
Collectively, these studies and our results support the
idea that the decrease of FSH induced by the lesion of
the DRN leads to the modification of the neuroendo-
crine mechanism that regulates FSH secretion.
An alternative explanation for the low concentrations
of FSH observed in the animals with DNR lesion is that
the lack of DRN serotonergic innervation results in the
activation of other neural pathways participating in the
control of gonadotropin secretion. We suggest that this
neural pathway is the serotonergic innervation arising
from the MRN; this suggestion is supported by the fact
that serotonergic innervation arising from the MRN in-
hibits the secretion of gonadotropins in the female rat
[3, 5]. The DRN and MRN nuclei are anatomically con-
nected [22]; thus, it is possible that the DRN controls
the functions of the MRN, as previously suggested [23].
The decrease in sperm count and FSH concentrations
observed in our work after chemical lesion of the DRN
is in line with reports that support the role of FSH as a
factor of germ cell proliferation [51–54]. In the case of
prepuberal-pubertal male rat, FSH increases between 30
and 40 days-of-age [55]. FSH is involved in the initiation
and maintenance of spermatogenesis; in prepuberal rats,
FSH acts in Sertoli cells, and stimulates the secretion of
growth factors essential for proliferation and differenti-
ation of germ cells [51, 53, 54]. The decrease of FSH
concentrations, induced by hypophysectomy in prepuberal
male rats, induces the degeneration of pachytene sper-
matocytes, secondary spermatocytes, and round sperma-
tids; whereas the treatment of these animals with FSH or
FSH plus LH decreased the degeneration of germ cells
[52, 56]. The studies mentioned and our results support
the idea that the diminution of FSH concentration, in-
duced by the chemical lesion of DRN, has a role in de-
creasing sperm production.
Spermatogenesis is a multi-factorial regulated process
that involves the participation of gonadotropins and an-
drogens, among other factors [51–54, 56]. The results
presented herein show that the decreases in the sperm-
atogenesis induced by the lesion of the DRN did not cor-
relate with changes in testosterone levels. This result
indicates that factors other than testosterone participate
in the modulation of spermatogenesis. One such factor
is FSH, which has been previously indicated [54]. An-
other possibility is that the diminution of FSH concen-
trations in the animals with a lesion on the DRN could
affect the Sertoli cell functions and spermatogenesis. Both
testosterone and FSH have a synergistic action on Sertoli
cells to maintain spermatogenesis [54]. The action of these
hormones is mediated through receptors [57], and FSH fa-
cilitates the synthesis of androgen protein binding in Ser-
toli cells [54, 57]. FSH, together with testosterone, prevents
apoptosis and promotes the survival of germ cells, mainly
spermatocytes and round spermatids, and are involved in
spermiation [51, 53]. Accordingly, this evidence supports
the interaction of testosterone and FSH with Sertoli Cells
for regulation of spermatogenesis. Based on these lines of
evidence, it is possible that the decrease in spermatogenesis
in the animals with a lesion in the DRN is related to the di-
minished action of testosterone, mediated in turn by the
diminution on FSH secretion.
The fact that, in the animals with lesion of the MRN,
FSH and testosterone concentrations were similar to those
observed in the respective sham operated group, indicates
Table 5 The presence of detached germ cells into the lumen of seminiferous tubules is stage-dependent. Mean number of tubules
with germ cells into the lumen 15 or 35 days after the lesion of the DRN (Mean ± S.E.M.)
Stages of the cycle of the seminiferous epitheliun
Age at sacrifice Group VII VIII X XII
45 Days
Control 0 1.0 ± 0.3 0.2 ± 0.1 1.6 ± 0.1
Sham DRN 1.4 ± 0.5 2.0 ± 0.6 0.4 ± 0.2 2.2 ± 0.5
Lesion DRN 5.8 ± 1.0b 11.0 ± 0.7a,b 0.8 ± 0.4 3.8 ± 0.5
65 Days
Control 0.2 ± 0.0 1.2 ± 0.5 0 0.8 ± 0.0
Sham DRN 0.8 ± 0.5 2.0 ± 0.1 0.3 ± 0.1 1.2 ± 0.4
Lesion DRN 7.0 ± 0.9a,b 11.2 ± 1.6a,b 1.4 ± 0.2a,b 7.6 ± 1.1a,b
Sham; sham operation; DRN, dorsal raphe nucleus
aP < 0.05 vs. Control; bP < 0.05 vs. Sham DRN (Two way ANOVA followed by Tukey 's test)
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that concentrations of these hormones were sufficient to
maintain the spermatogenesis.
The fact that, 35 days after the lesion of the MRN, the
concentrations of FSH and sperm traits were not altered,
indicates that the serotonergic system arising from the
MRN, is not involved in the regulation of FSH secretion
and spermatogenesis. Possibly, the lack of serotonergic
innervation arising in the MRN, is compensated by the
presence of serotonergic system arising from the DRN,
which exerts a stimulatory role on secretion of FSH and
spermatogenesis. This idea is supported by the existence
of a neural connection between the DRN and MRN, as
previously proposed [22].
The testicular effects of lesion of the DRN are transient.
The opposite pattern of proportion of stages of cycle of
seminiferous epithelium, with positive or negative devia-
tions of independence, between animals of 45 and 65-days-
of-age, and the higher values of the area of seminiferous
tubules at 65 days-of-age, indicates the progression of the
testicular development. This assumption is supported by
the increase in weight of the testis and accessory glands in
animals with lesion of the DRN at 65 days-of-age com-
pared with those of 45-days-of-age.
The lesion of the DRN did not affect the concentra-
tions of either LH or sexual steroids. This indicates
that functionality of Leydig cells was not altered. Previ-
ous evidence supports this assertion that, in the rat,
testosterone synthesis occurs mainly in the testis and
secretion by the adrenal gland is limited, since the re-
moval of testis resulted in lower testosterone serum
levels and adrenalectomy did not modify testosterone
serum levels [58].
Together our results show that serotonin arising from
the DRN is involved in the modulation of the testis func-
tion. Thus the drugs that enhance or inhibit serotonin ac-
tivity may have implications on reproduction. The use of
antidepressants such as selective serotonin reuptake inhib-
itors (SSRI) induce negative reproductive effects in adult
men [59], in woman during pregnancy [60], and male ex-
posed in utero [61]. SSRI and are widely prescribed for
children and adolescents, although data regarding their
safety are limited [62]. Recently, a detailed description of
disruption of the axis hypothalamus-hypophysis-testicle
by SSRI was described in mature male zebrafish (Prasad et
al., in press [63]), but information on mammal models is
still scarce.
Conclusions
Here we demonstrate that serotonergic system, arising
from the DRN and MRN, participates differentially in the
modulation of the neuroendocrine mechanisms that regu-
late testicular function. In light of our results, the use of
prescription or abuse drugs which affect the serotonergic
system, could impact the activity of DRN and MRN nu-
clei, and thus affect the male reproductive function.
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